It is currently Tue Jun 30, 2015 11:48 pm
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
LAnBfflo wrote:Hello everyone.
I'm really happy I came across this site. It's been almost 3 years (2 weeks shy) since I was diagnosed.
I've been on steroids, beta seron, tysabri, and ivig with steroids. My initial diagnosis was RRMS, but found out Monday my new doc thinks it's SPMS. I'm so-o-o-o-o thrilled, as you can imagine.
I can't believe I haven't found this sooner!
Anyway, I'm really happy to have found this site.
See y'all around. ...
Total posts 226223 • Total topics 23788 • Total members 15094